• Aucun résultat trouvé

[PDF] Top 20 Alcoholic liver disease: when to consider liver transplantation?

Has 10000 "Alcoholic liver disease: when to consider liver transplantation?" found on our website. Below are the top 20 most common "Alcoholic liver disease: when to consider liver transplantation?".

Alcoholic liver disease: when to consider liver transplantation?

Alcoholic liver disease: when to consider liver transplantation?

... undergo liver transplantation for alcoholic liver disease (ALD), alcohol relapse is ...return to abu- sive or excessive drinking likely decreases overall survival; however, the ... Voir le document complet

16

Letter to the Editor: No Baclofen for Alcohol Use Disorders Even More When Liver Disease Is Serious!

Letter to the Editor: No Baclofen for Alcohol Use Disorders Even More When Liver Disease Is Serious!

... 1 Caputo F, Domenicali M, Bernardi M. Diagnosis and treatment of alcohol use disorder in patients with end-stage alcoholic liver disease. Hepatology 2018. Online Nov 24. doi: 10.1002/hep.30358. 2 ... Voir le document complet

3

en
                                                                    fr

en fr Progression and diagnostic methods in non-alcoholic fatty liver disease Progression et tests diagnostiques de la stéatose hépatique non alcoolique

... clinicians to pay particular attention to the operators when interpreting dynamic changes of TE ...analysis to the same, experienced operator somehow reduced the variability (a one-class ... Voir le document complet

181

Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease

Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease

... hypotheses to explain the selective hepatic insulin resistance involve extrahepatic pathways from peripheral metabolic organs [ 112 ], which underscores the multi-organ dimension of NAFLD ...contributing to ... Voir le document complet

54

Identifying PGC-1α-dependent hepatokines in a non-alcoholic fatty liver disease murine model

Identifying PGC-1α-dependent hepatokines in a non-alcoholic fatty liver disease murine model

... fatty liver disease (NAFLD) has become a serious public health problem and is now considered as the major cause of liver disease ...of liver diseases starting with non-alcoholic ... Voir le document complet

82

Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation

Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation

... of liver transplantation over the past years, we need to be more reactive regarding the indication of liver trans- plantation in the most severe patients, ...ICU. When a patient is ... Voir le document complet

6

In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal

In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal

... organoids; liver-on-a-chip; cell culture 1. Introduction Non-alcoholic fatty liver disease (NAFLD) comprises two histological forms: non- alcoholic fatty liver (NAFL) and ... Voir le document complet

19

Endoplasmic Reticulum stress signaling and the pathogenesis of Non-Alcoholic Fatty Liver Disease

Endoplasmic Reticulum stress signaling and the pathogenesis of Non-Alcoholic Fatty Liver Disease

... the liver. In response to an increased protein-folding load in the ER, PERK can phosphorylate and stabilize NRF2 to compensate for high ROS levels, which are important mediators of inflammation (34, ... Voir le document complet

56

DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease

DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease

... of alcoholic fatty liver and liver injury in mice Our previous studies indicate that hepatic overexpression of SIRT1, a master nutrient sensor, inhibits mTORC1 activity and attenuates hepatic ... Voir le document complet

31

Roles of Ceramides in Non-Alcoholic Fatty Liver Disease

Roles of Ceramides in Non-Alcoholic Fatty Liver Disease

... clear when exploring mice models invalidated for enzymes of the sphingolipid ...resistant to hepatic fibrosis induced by bile duct ligation or carbon tetrachloride (CCl4) [ 124 , 129 ...difficult to ... Voir le document complet

20

Pathogenic role of IL-15 in non-alcoholic fatty liver disease

Pathogenic role of IL-15 in non-alcoholic fatty liver disease

... ability to mimic IL-2–induced T-cell proliferation, the biochemical and functional relationship between these two cytokines were examined in ...starts when the cytokines bind IL-2Rα or IL-15Rα, ... Voir le document complet

101

Right lobe living-related liver transplantation in a Jehovah's Witness

Right lobe living-related liver transplantation in a Jehovah's Witness

... Fig. 1 Abdominal computed tomodensitometry showing 80% spleen embolization of the enlarged spleen and ascites References 1. Detry O, Honore´ P, Delwaide J, Dondelinger RF, Meurisse M, Jacquet N. Liver ... Voir le document complet

2

Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study

Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study

... fatty liver disease (NAFLD), the most prevalent liver disease ...is to determine the relationship between cannabis use and the prevalence of NAFLD in ...9.4) to determine the ... Voir le document complet

17

Nonalcoholic fatty liver disease and obstructive sleep apnea

Nonalcoholic fatty liver disease and obstructive sleep apnea

... Nonalcoholic liver fatty liver disease (NAFLD) is a highly prevalent condition and its prevalence is increasing in parallel with the epidemic of obesity and type-2 diabetes ...6 to 33% in the ... Voir le document complet

28

Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?

Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?

... GM to improve liver alterations seem an ideal alternative to weight ...parameters. To date, the probiotic field is the most advanced with human RCT showing small yet significant improvement in ... Voir le document complet

38

The veno-occlusive disease of the liver.

The veno-occlusive disease of the liver.

... a liver transplant for acute VOD have become long-term ...importance to identify signs of VOD as early as possible, so that supportive care can be adapted ...or liver infections is critical because ... Voir le document complet

8

Cell and tissue engineering for liver disease

Cell and tissue engineering for liver disease

... genetically to harbor mutations of interest, opens the door for patient- specific assessment of liver disease, susceptibility to pathogens, and efficacy of candidate ...paid to the ... Voir le document complet

50

Should ABO-incompatible deceased liver transplantation be reconsidered?

Should ABO-incompatible deceased liver transplantation be reconsidered?

... donor liver transplantation (LDLT) has been established first in children and afterwards in ...justified when no ABOc living donor is available as there is no possibility of ABOc DDLT and because AB- ... Voir le document complet

2

Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment

Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment

... contribute to improved fundamental knowledge of NAFLD etiopathogenesis in the context of gene x diet ...contributing to early stages of ...reducing liver histopathology, potentially though ... Voir le document complet

11

Transplantation of hESC-derived hepatocytes protects mice from liver injury

Transplantation of hESC-derived hepatocytes protects mice from liver injury

... up to the hepatoblast ...subjected to a 1- day treatment with 100 ng/ml Activin A (CellGenix), 100 ng/ml basic (b)FGF (CellGenix), 10 ng/ml BMP4 (R&D Systems), 10 μM LY294002 (Cayman Chemical Company) ... Voir le document complet

18

Show all 10000 documents...